Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03979794 · ClinicalTrials.gov registry record · NA

A Distress Screening and Intervention in Cancer Surgery

A NA study, sponsored by Baylor College of Medicine.

Terminated
Registry status
NA
Development phase
16
Enrollment target

NCT03979794: Clinical Trial NA study, sponsored by Baylor College of Medicine.

NCT03979794 is a NA study that was terminated before completion, run by Baylor College of Medicine. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03979794, a NA study, was terminated before completion, sponsored by Baylor College of Medicine.

TERMINATED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

The goal of this project is to examine initial effectiveness of a brief (2 preoperative, 2 postoperative session) cognitive behaviorally-based telephone intervention compared to standard care on postoperative outcomes for patients who are scheduled to undergo a cancer-related surgery in 12 or more days and screen positive for distress (4 or higher on 0-10 Distress Thermometer). The intervention focuses on improving emotional and physical health through relaxation, behavioral activation, increased physical activity, and adherence to medication and wound care. Participants will be randomly assigned to receive the intervention or to receive standard care. Outcomes assessed 4 and 6 weeks post-operatively will include: Depression (Patient Health Questionnaire-8), anxiety (Generalized Anxiety Disorder-7), health-related QOL (SF-36 MCS and PCS), number and type of complications, length of stay, and 30-day readmission.

Primary Outcome

PHQ-8 assesses depression symptoms; A total score (range: 0-24) will be used with higher scores representing more depressive symptoms.

Interventions

  • BEHAVIORAL Behavioral Intervention for Wellness and Engaged Living (Be-WEL)

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2020-12-17
Est. Completion 2024-11-12
Phase NA
Baylor College of Medicine

616 total trials

Why NCT03979794 stopped before completion

NCT03979794 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Behavioral Intervention for Wellness and Engaged Living (Be-WEL) is the first listed.

NCT03979794 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03979794 about?

NCT03979794 is a clinical study titled "A Distress Screening and Intervention in Cancer Surgery". The goal of this project is to examine initial effectiveness of a brief (2 preoperative, 2 postoperative session) cognitive behaviorally-based telephone intervention compared to standard care on postoperative outcomes for patients who are scheduled to undergo a cancer-related surgery in 12 or more d...

What is the current status of trial NCT03979794?

This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2020-12-17. Estimated completion is 2024-11-12.

What interventions are being tested in trial NCT03979794?

The interventions under investigation include: Behavioral Intervention for Wellness and Engaged Living (Be-WEL) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03979794?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03979794's enrollment target sits among peer trials

16 1871st of 2000 higher than 120 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03979794, the US trial registry maintained by the National Library of Medicine. NCT03979794 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.